VolitionRX Limited (VNRX)
Volition Announces MARS Consortium Clinical Study SuggestsNu.Q® H3.1. Concentrations are Closely Associated with Sepsis and Organ Failure
Volition Announces MARS Consortium Clinical Study SuggestsNu.Q® H3.1. Concentrations are Closely Associated with Sepsis and Organ Failure
There are no comments here yet...